FDA accelerated path and Risto-cel 2026 catalysts, strong cash runway to 2029—read now. Click for more on BEAM.
Alifeliz #DominicanBoxing #toprankboxing Ali Feliz Dominican Prospect 🇩🇴Super Fast For A Heavyweight👀 #Boxing ...
The Raja Saab worldwide box office collection day 4: Prabhas film faring worse than Adipurush, Saaho; crawls to ₹170 cr Viral ...
Discover the fascinating world of unique organisms, like the tardigrade and spiny-headed worm, that have developed incredible ...
A significant 76% of multiresident households with prediabetes patients have additional members with diabetes risk factors, ...
Mitapivat is the first FDA-approved oral therapy for anaemia in all forms of thalassemia Reduced transfusion dependence may ...
Congenital factor VII deficiency is a rare, autosomal recessive disorder with an estimated prevalence of 1 in 1,000,000. We ...
Higher levels of fetal hemoglobin may guard against lung problems and delay bone damage in people with sickle cell disease, ...
The company in 2026 is seeking approval from global regulators for Casgevy and two cystic fibrosis drugs in younger patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback